Posters
Sunday, October 8, 2017
•
Area B
•
8:30 AM
>
5:00 PM
•
Posters
•
Poster Area B
•
P22-01
•
A comparison of loop electrosurgical excision procedure using a ring-shaped loop versus a right-angled triangular loop
See abstract
>
J.
Jung Eun
KIM
•
P22-02
•
Post-Coital Bleeding (PCB) as a Predictor for Cervical Pathology : A cross Sectional Study
See abstract
>
R.
Regina
AGIZIM
•
P22-03
•
Progression of cervical intraepithelial neoplasia in pregnancy
See abstract
>
D.
Donata
GRIMM
•
P22-04
•
Association between vaginal microbiome, high risk HPV profile, HPV E6/E7 RNA expression and severity of cervical precancerous lesions
See abstract
>
I.
Irina
JERMAKOVA
•
P22-05
•
The discovery of a antitumor activity of the alkaloid Erythralin: induction of apoptosis in SiHa cells by arresting the cell cycle at the G2-M phase
See abstract
>
J.
Janaina
CRISPIM
•
P22-06
•
Citotoxic and pro apoptotic activities of Croton blanchetianus in human cervical cancer HeLa and SiHa cells
See abstract
>
J.
Janaina
CRISPIM
•
P24-01
•
Vulvar intraepithelial neoplasia-HPV induced pathology?
See abstract
>
M.
Mihai
MITRAN
•
P24-02
•
Etiological role of human papillomavirus infection in the development of penile cancer
See abstract
>
J.
Jiro
SAKAMOTO
•
P25-01
•
Factors associated with abnormal anal cytology or HR-HPV anal infection among HIV positive MSM
See abstract
>
F.
Filip
ROB
•
P25-02
•
HPV genotyping and E6/E7 HPV mRNA expression analyses in anal cytology samples for prevention of HPV-related anal cancer.
See abstract
>
F.
Francesca
CAROZZI
•
P25-03
•
Anal intraepithelial neoplasia (AIN) and anal squamous cell carcinoma (SCC) in a large urban cohort of HIV-positive individuals living in the United Kingdom: a retrospective data analysis
See abstract
>
J.
Jaime
VERA
•
P25-04
•
Human papillomavirus (HPV) and the prognosis of Brazilian patients with anal carcinoma
See abstract
>
V.
Vera
SADDI
•
P26-01
•
HPV detection in oral cavity of asymptomatic people from North Argentina
See abstract
>
G.
Gerardo
DELUCA
•
P26-02
•
Prevalence of HPV-16 and 18 in patients with oral leukoplakia: a preliminary molecular and immunohistochemical study from a Brazilian cohort
See abstract
>
G.
Glauco Issamu
MIYAHARA
•
P26-03
•
DNA damage response as tumor selective radiosensitization strategy for HPV positive and negative head and neck cancers
See abstract
>
R.
Rüveyda
DOK
•
P27-01
•
DNA damage response as tumor selective radiosensitization strategy for HPV positive and negative head and neck cancers
>
R.
Rüveyda
DOK
•
P27-02
•
Prevalence and impact on survival of HPV and P16 in oropharyngeal cancer other than tonsil or base of tongue cancer
See abstract
>
L.
Linda
MARKLUND
•
P27-03
•
Comparison of Anyplex II HPV 28 and SPF10/DEIA/LiPA25 in FFPE oropharyngeal cancer samples
See abstract
>
M.
Miquel Angel
PAVÓN
•
P27-04
•
The prevalence of HPV in head and neck squamous cell cancer tissues of patients from South-Central Poland
See abstract
>
A.
Anna
JANECKA-WIDLA
•
P27-05
•
Histological subtype of squamous cell carcinoma of head and neck and the presence of HPV assessed by th immunoxession of P16
See abstract
>
L.
Luiz Martins
COLLACO
•
P27-06
•
TP53 and the association to Afatinib response in HNSCC cell lines
See abstract
>
L.
Lidia Maria
ARANTES
•
P27-07
•
The role of p16 in the metastasis process of human papillomavirus positive head and neck cancers
See abstract
>
M.
Mary
GLORIEUX
•
P27-08
•
Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: a prospective study
See abstract
>
L.
Lars
SIVARS
•
P27-09
•
The couple management of HPV infection
See abstract
>
S.
Sorin
PUIA
•
P27-10
•
Expressed HPV integration events in head and neck cancer: where they occur and their effects on survival and molecular signatures
>
M.
Maureen
SARTOR
•
P27-11
•
The prognostic utility of HPV specific testing in addition to p16 immunohistochemistry in oropharyngeal carcinoma.
See abstract
>
S.
Selvam
THAVARAJ
•
P27-12
•
Frequency and clinical outcome of HPV-driven oropharyngeal carcinoma in North-East Italy
See abstract
>
A.
Annarosa
DEL MISTRO
•
P27-13
•
Prevalence of HPV in branchial cleft cysts and the use of HPV in diagnosis of cystic lesions of the neck
See abstract
>
D.
David
LANDIN
•
P27-14
•
Expressed HPV integration events in Head and Neck cancer: where they occur and their effect on survival and molecular signatures
See abstract
>
M.
Maureen
SARTOR
•
P28-01
•
E6 proteins of alpha and beta cutaneous HPV types differ in their ability to potentiate Wnt signaling
See abstract
>
L.
Levana
SHERMAN
•
P29-01
•
Low vaccine coverage but near extinction of HPV 6 and genital warts in young women in Wolfsburg, Germany
See abstract
>
A.
Alexander
LUYTEN
•
P30-01
•
Accurate and specific detection of 13 genotypes associated with sexually transmitted disease by PNA mediated real time PCR
See abstract
>
E.
Eunji
JEONG
•
P30-02
•
HPV infection among HIV-positive men: A four year revised experience of a diagnosis Laboratory.
See abstract
>
A.
Ana
ALBUQUERQUE
•
P32-01
•
Estimating the epidemiological impact and cost effectiveness of the new nonavalent HPV vaccine in Spain
See abstract
>
N.
Noelia
LÓPEZ
•
P32-02
•
Gardasil 9: accelerated reduction in the incidence and costs of HPV-related precancerous lesions and cancers
See abstract
>
J.
Jens
OLSEN
•
P32-03
•
Cost-effectiveness of cervical cancer screening in Europe- a systematic review with specific interest on risk-adapted strategies
See abstract
>
G.
Gaby
SROCZYNSKI
•
P34-01
•
A survey of HPV knowledge and attitudes toward HPV vaccination among the middle school students and their parents in China
See abstract
>
X.
Xiang Xian
FENG
•
P34-02
•
HPV- What do they know: evaluation of medicine students and health professionals- Valença- Rio de Janeiro/ Brazil
See abstract
>
F.
Filomena
SILVEIRA
•
P36-01
•
Well-Child Visits and HPV Vaccination in Preteenagers Aged 11-12 Years during 2007-2015 in the United States
See abstract
>
S.
Smita
KOTHARI
•
P36-02
•
Acceptability and short-term effects of an HPV vaccination intervention for young gay and bisexual men in the United States
See abstract
>
P.
Paul
REITER
•
P36-03
•
Digital Interventions to Improve HPV Vaccine Uptake
See abstract
>
W.
William
WOODALL
•
P36-04
•
Croatian pathway in implementing HPV vaccination (2007.-2017.)
See abstract
>
N.
Neda
FERENCIC VRBAN
•
P36-05
•
HPV prevalence and associated risk factors in women with cervical pre-cancer and cancer in Switzerland at the beginning of the cantonal vaccination programmes: The CIN3+plus study
See abstract
>
A.
Anne
SPAAR
•
P36-06
•
HPV vaccine acceptability for daughters among at-risk women in Brazil
See abstract
>
L.
Laura
MUSSELWHITE
•
P36-07
•
Stratifying a screening population into risk categories-personalising a cervical cancer screening programme
See abstract
>
N.
Nicolas
BALTZER
|